专题:Viral Infectious Diseases and Gene Expression in Insects

This cluster of papers focuses on the production of recombinant proteins, particularly in mammalian and insect cells. It covers topics such as transient transfection, baculovirus expression systems, glycosylation, virus-like particles, and monoclonal antibody production. The research also delves into cell culture processes and biopharmaceutical production.
最新文献
Toward precision in nanoscale IR spectroscopy: Optimizing biological sample preparation for molecular and morphological integrity

article Full Text OpenAlex

Fitness Landscape for Antibodies 2: Benchmarking Reveals That Protein AI Models Cannot Yet Consistently Predict Developability Properties

article Full Text OpenAlex

Optical Fiber pH and Dissolved Oxygen Sensors for Bioreactor Monitoring: A Review

article Full Text OpenAlex

Multi-response optimization of defined and undefined serum-free media for enhanced proliferation of immortalized lamb muscle cells

article Full Text OpenAlex

Oncolytic virus and immunogenic cell death in cancer therapy

article Full Text OpenAlex

Hybrid Modeling for Bioprocesses: Architectures, Applications, and Perspectives

article Full Text OpenAlex

Complete neutralizing antibody evasion by serodivergent non-mammalian AAVs enables gene therapy redosing

article Full Text OpenAlex

Machine learning methods for small data and upstream bioprocessing applications: A comprehensive review

article Full Text OpenAlex

Multiple rotavirus species encode fusion-associated small transmembrane (FAST) proteins with cell type-specific activity

article Full Text OpenAlex

Consensus guidelines for cellular label-free optical metabolic imaging: ensuring accuracy and reproducibility in metabolic profiling

article Full Text OpenAlex

近5年高被引文献
CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting

article Full Text OpenAlex 1507 FWCI196.8863

Long-term outcomes following CAR T cell therapy: what we know so far

review Full Text OpenAlex 1172 FWCI273.1187

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

article Full Text OpenAlex 894 FWCI84.9673

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

review Full Text OpenAlex 595 FWCI59.6445

Therapy with oncolytic viruses: progress and challenges

review Full Text OpenAlex 481 FWCI152.4761

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

review Full Text OpenAlex 463 FWCI42.5925

Biopharmaceutical benchmarks 2022

article Full Text OpenAlex 456 FWCI35.8253

CAR T therapy beyond cancer: the evolution of a living drug

review Full Text OpenAlex 433 FWCI100.9909

CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn

review Full Text OpenAlex 432 FWCI100.7577

Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion

review Full Text OpenAlex 351 FWCI34.6446